Press releases

SurvivX CEO invited as keynote speaker at Hollandbio Event

To celebrate the arrival of a new 'Customized Health' program from Hollandbio, and event has organised called "Biotech Wednesday" on November 15. Our CEO, Remko van Leeuwen has been invited as keynote…
Lees verder

SurvivX highlighted during summit with Netherlands PM Mark Rutte in India

Our novel sepsis treatment, called SUR-101, which we develop collaboratively by the Centre for Cellular and Molecular Platforms (C-CAMP) and the Institute of Life Sciences in India, was official licensed to Dutch…
Lees verder

Financiering voor SurvivX: verder onderzoek naar medicijn voor de behandeling van sepsis

Met een investering vanuit het Vroegefasefinanciering Gelderland kan het Nijmeegse SurvivX verder met de ontwikkeling van een medicijn tegen sepsis.
Lees verder
See all our articles